Professor Nathan Peiffer-Smadja distinguished in the TIME France Health 2026 ranking
Professor Nathan Peiffer-Smadja, a lecturer and researcher at the Faculty of Health of Université Paris Cité, has just received prestigious international recognition. He is among the winners of the "TIME France Health 2026" list, a distinction that highlights the excellence of his work in the field of medical research.
This ranking highlights individuals whose research has a significant impact on global public health. Professor Peiffer-Smadja is particularly recognized for his studies on drug repurposing, a method that involves using already approved treatments to treat new pathologies.
His research has notably attracted the attention of the international scientific community, including that of the Food and Drug Administration (FDA) in the United States. This repurposing work is considered a promising strategy for accelerating access to effective therapies while reducing costs and clinical development timelines.
This nomination testifies to the dynamism of French research within Université Paris Cité. By joining this list, Professor Peiffer-Smadja confirms his role as a key player in current medical innovation, offering new hope for the care of many patients.